DK1467761T3 - Behandling af neovaskulære oftalmiske sygdomme - Google Patents

Behandling af neovaskulære oftalmiske sygdomme

Info

Publication number
DK1467761T3
DK1467761T3 DK02787238T DK02787238T DK1467761T3 DK 1467761 T3 DK1467761 T3 DK 1467761T3 DK 02787238 T DK02787238 T DK 02787238T DK 02787238 T DK02787238 T DK 02787238T DK 1467761 T3 DK1467761 T3 DK 1467761T3
Authority
DK
Denmark
Prior art keywords
treatment
ophthalmic diseases
neovascular ophthalmic
neovascular
ilk
Prior art date
Application number
DK02787238T
Other languages
Danish (da)
English (en)
Inventor
Jing-Song Tao
Philippe Maria Clotai Margaron
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Application granted granted Critical
Publication of DK1467761T3 publication Critical patent/DK1467761T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK02787238T 2001-11-30 2002-11-29 Behandling af neovaskulære oftalmiske sygdomme DK1467761T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33528701P 2001-11-30 2001-11-30
PCT/CA2002/001859 WO2003045432A1 (en) 2001-11-30 2002-11-29 Treatment of neovascular ophthalmic disease

Publications (1)

Publication Number Publication Date
DK1467761T3 true DK1467761T3 (da) 2007-02-05

Family

ID=23311112

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02787238T DK1467761T3 (da) 2001-11-30 2002-11-29 Behandling af neovaskulære oftalmiske sygdomme

Country Status (10)

Country Link
US (1) US20050074455A1 (pt)
EP (1) EP1467761B1 (pt)
AT (1) ATE344054T1 (pt)
AU (1) AU2002351908A1 (pt)
CA (1) CA2466864A1 (pt)
DE (1) DE60215864T2 (pt)
DK (1) DK1467761T3 (pt)
ES (1) ES2275933T3 (pt)
PT (1) PT1467761E (pt)
WO (1) WO2003045432A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2454976C (en) * 2001-07-26 2011-05-10 Santen Pharmaceutical Co., Ltd. Therapeutic agent for glaucoma comprising compound having pi3 kinase inhibitory action as active ingredient
US7479277B2 (en) * 2005-02-24 2009-01-20 Wisconsin Alumni Research Foundation Method for reducing intraocular pressure using integrin-linked kinase inhibitor
WO2010129775A1 (en) 2009-05-06 2010-11-11 University Of Virginia Patent Foundation Self-illuminated handheld lens for retinal examination and photography and related method thereof
IT201800005693A1 (it) * 2018-05-24 2019-11-24 Apparecchiatura per trattamenti biofotonici tissutali

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001622A (en) * 1995-12-21 1999-12-14 Sunnybrook Health Science Centre Integrin-linked kinase and its use
US6833436B2 (en) * 1997-05-21 2004-12-21 Children's Medical Center Corporation Short peptides which selectively modulate the activity of serine/threonine kinases
CA2245029A1 (en) * 1998-03-13 1999-09-13 University Of British Columbia Granulatimide compounds as g2 checkpoint inhibitors
US6242442B1 (en) * 1998-12-17 2001-06-05 Alcon Laboratories, Inc. Brinzolamide and brimonidine for treating ocular conditions
US6177273B1 (en) * 1999-10-26 2001-01-23 Isis Pharmaceuticals Inc. Antisense modulation of integrin-linked kinase expression
US6420400B1 (en) * 2000-04-07 2002-07-16 Kinetek Pharmaceuticals, Inc. Antiproliferative 1,2,3-thiadiazole compounds
US6214813B1 (en) * 2000-04-07 2001-04-10 Kinetek Pharmaceuticals, Inc. Pyrazole compounds
US6436915B1 (en) * 2000-04-07 2002-08-20 Kinetek Pharmaceuticals, Inc. Pyrazole compounds
US7022702B2 (en) * 2000-04-07 2006-04-04 Qlt Inc. Antiproliferative 1,2,3-thiadiazole compounds
US6403588B1 (en) * 2000-04-27 2002-06-11 Yamanouchi Pharmaceutical Co., Ltd. Imidazopyridine derivatives
DK1277754T3 (da) * 2000-04-27 2005-11-14 Astellas Pharma Inc Imidazopyridinderivater

Also Published As

Publication number Publication date
US20050074455A1 (en) 2005-04-07
EP1467761B1 (en) 2006-11-02
DE60215864T2 (de) 2007-05-31
PT1467761E (pt) 2007-02-28
ATE344054T1 (de) 2006-11-15
ES2275933T3 (es) 2007-06-16
AU2002351908A1 (en) 2003-06-10
CA2466864A1 (en) 2003-06-05
WO2003045432A8 (en) 2003-08-14
WO2003045432A1 (en) 2003-06-05
DE60215864D1 (de) 2006-12-14
EP1467761A1 (en) 2004-10-20
AU2002351908A8 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
EA200400518A1 (ru) Способы лечения глазных неоваскулярных заболеваний
ATE330249T1 (de) Optik mit erweiterter schärfentiefe für das menschliche sehen
DE60140046D1 (de) Ophthalmische linsensysteme
DK1509121T3 (da) Okulærvisningsapparat til behandling af øjenlidelser
DE502005011119D1 (pt)
HK1125184A1 (en) Ophthalmic lens element for myopia correction
WO2004004757A8 (en) Treatment for eye disorder
WO2003005941A3 (de) Insert zur behandlung des trockenen auges
AR035118A1 (es) Metodos para disenar lentes oftalmicas multifocales
DE60101265D1 (de) Behandlung von augenschmerzen
CY1108983T1 (el) Μιμητικα της υπεροξειδικης δισμουτασης για την αγωγη οφθαλμικων διαταραχων και νοσων
DE502004010981D1 (de) Intraokulare linseneinrichtung zur verbesserung des sehvermögens bei netzhauterkrankungen
DK1467761T3 (da) Behandling af neovaskulære oftalmiske sygdomme
WO2008042314A3 (en) Diagnosis and treatment of disorders of the eye
PT1131073E (pt) Uso de derivados de estaurosporina para o tratamento de doencas oculares neovasculares
AU2001267864A1 (en) Remedial agent for optic nerve disease and the like
DE60124093D1 (de) S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.
USD910189S1 (en) Eye patch device
WO2002015942A8 (en) Method for the identification of agents that inhibit or promote cataracts and uses thereof
CY1117505T1 (el) Απταμερη δεσμευσης του συμπληρωματος και παραγοντες εναντι toy c5 χρησιμα στην αγωγη εναντι οφθαλμικων διαταραχων
UA86346C2 (ru) Способ лечения открытоугольной глаукомы
SE0001925D0 (sv) Methods of obtaining ophthalmic lenses capable of reducing the aberrations of the eye
RU2005109684A (ru) Способ лечения заболеваний заднего отдела глаза
CY1114337T1 (el) Γονιδιακη μεταφορα με την μεσολαβηση φορεα λεντοϊων και χρησεις αυτης
ES1049629Y (es) Un protector ocular.